Full-Time

Regional Site Liaison

Clinical Operations

Confirmed live in the last 24 hours

BlueRock Therapeutics

BlueRock Therapeutics

201-500 employees

Develops advanced cellular therapies for diseases

Biotechnology

Mid

Remote in USA

Position can be based remotely anywhere in the United States.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Minimum of a Bachelors’ degree (BS preferred) in a scientific field of study with a minimum of 4 years of relevant experience working in the clinical trial setting (i.e., either at a clinical site or in the pharmaceutical/ biotech industry) required.
  • Experience/knowledge in Neurology, Ophthalmology, Immunology preferred, with the ability to learn future therapeutic areas/disease states.
  • Ability to build and maintain strong relationships and credibility with investigative site personnel.
  • Exceptional customer service skills with excellent leadership, interpersonal and communication skills and deep understanding/appreciation of the working relationships between investigative sites, CRA/CRO and the Sponsor.
  • Have experience with site operations and be knowledgeable about the conduct and monitoring of clinical studies.
  • Have an awareness of local country requirements including necessary institutional/health authority approvals (e.g., IRBs, FDA, EMEA, etc.).
  • Possess strong organizational skills with an ability to align priorities, lead multiple tasks/activities and manage time independently.
Responsibilities
  • Building a global network of physician investigators in the areas of Neurology, Ophthalmology, Immunology and future therapeutic areas of interest to BlueRock.
  • Providing country/regional clinical operations expertise and local sponsor oversight of clinical sites to optimize quality and execution of BRT studies.
  • Possessing operational knowledge of the protocol and having the ability to answer site questions and/or assist connecting the site to BRT and/or CRO personnel who can.
  • Partnering with the local CRA, supporting CRA’s relationship with site personnel and assisting with issue resolution at the site.
  • Assessing CRA/CRO performance through regular contact with the site personnel.
  • Attending/scheduling start-up and interim meetings (remote and in person) with site personnel; includes attendance at QVs, SSVs, SIVs and IMs.
  • Facilitating/conducting 'insight sessions' with study coordinators and other site personnel during study/protocol planning, logistics, site and patient burden, etc. Also conduct these sessions when enrollment is behind projected timelines.
  • Monitoring site performance metrics on individual studies, e.g., training completion, start-up timelines, enrollment performance, etc., assisting the site, as necessary.
  • Developing and implementing site-level recruitment plans (or oversight of CRO development on site-level recruitment plans).
  • Conducting and completing sponsor oversight visit reports.
  • For studies including surgery, working closely with Clinical Site Liaison (CSL), facilitating their interactions with the sites to enable successful surgeries; includes assisting/attending 'mock' surgical site runs.
  • Partnering with CDST and CRO on site identification, feasibility, qualification, initiation, and closeout activities.
  • Providing support to BRT study teams by being the single point of contact for information exchange, issue escalation/resolution as they relate to either the CRA and/or the site.
BlueRock Therapeutics

BlueRock Therapeutics

View

BlueRock Therapeutics develops advanced cellular therapies using a unique cell gene platform that directs cellular differentiation and genetically engineers cells. This allows them to create new types of medicines aimed at treating diseases in neurology, cardiology, and immunology. Their products work by transforming cells to target complex medical conditions such as neurodegenerative diseases, heart failure, and immune disorders. Unlike many competitors, BlueRock focuses specifically on these challenging areas and collaborates with healthcare providers, research institutions, and pharmaceutical companies to bring their therapies to market. The company's goal is to advance regenerative medicine through extensive research and development, strategic partnerships, and eventually commercializing their therapies after obtaining regulatory approval.

Company Stage

Acquired

Total Funding

$218.9M

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

3%

1 year growth

6%

2 year growth

21%
Simplify Jobs

Simplify's Take

What believers are saying

  • The FDA's RMAT designation for bemdaneprocel highlights BlueRock's potential to bring groundbreaking treatments for Parkinson's disease to market.
  • Successful Phase I trials and upcoming Phase II studies for bemdaneprocel indicate promising advancements in their pipeline, potentially leading to significant clinical and commercial success.
  • Collaborations with companies like Rune Labs and bit.bio demonstrate BlueRock's commitment to leveraging cutting-edge technologies and partnerships to accelerate innovation.

What critics are saying

  • The highly specialized nature of their therapies means that any setbacks in clinical trials could significantly impact their progress and financial stability.
  • Dependence on strategic partnerships and licensing agreements may limit their control over the development and commercialization of their therapies.

What makes BlueRock Therapeutics unique

  • BlueRock Therapeutics leverages a unique cell gene platform to direct cellular differentiation and genetically engineer cells, setting it apart from competitors in the regenerative medicine space.
  • Their focus on neurology, cardiology, and immunology allows them to target some of the most challenging and high-impact medical conditions, unlike companies with a broader but less specialized approach.
  • Strategic partnerships with leading pharmaceutical companies and innovative biotech firms like bit.bio enhance their R&D capabilities and market reach.

Help us improve and share your feedback! Did you find this helpful?